Bilezikian JP - Search Results

1

Evolving toward a new paradigm for prevention of osteoporosis--the time is upon us.

Rosen C, Bilezikian JP. Rosen C, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 1997 Sep;82(9):2782-3. doi: 10.1210/jcem.82.9.4237. J Clin Endocrinol Metab. 1997. PMID: 9284695 No abstract available.

2

Insulin-like growth factor-I in men with idiopathic osteoporosis.

Kurland ES, Rosen CJ, Cosman F, McMahon D, Chan F, Shane E, Lindsay R, Dempster D, Bilezikian JP. Kurland ES, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 1997 Sep;82(9):2799-805. doi: 10.1210/jcem.82.9.4253. J Clin Endocrinol Metab. 1997. PMID: 9284699

3

Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density.

Rosen CJ, Kurland ES, Vereault D, Adler RA, Rackoff PJ, Craig WY, Witte S, Rogers J, Bilezikian JP. Rosen CJ, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 1998 Jul;83(7):2286-90. doi: 10.1210/jcem.83.7.4964. J Clin Endocrinol Metab. 1998. PMID: 9661596 Clinical Trial.

4

Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I.

Kurland ES, Chan FK, Rosen CJ, Bilezikian JP. Kurland ES, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 1998 Jul;83(7):2576-9. doi: 10.1210/jcem.83.7.4971. J Clin Endocrinol Metab. 1998. PMID: 9661647 Clinical Trial.

5

Perplexing polymorphisms: D(i)ps, Sn(i)ps, and trips.

Rosen CJ, Bilezikian JP. Rosen CJ, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 1999 Dec;84(12):4465-6. doi: 10.1210/jcem.84.12.6211. J Clin Endocrinol Metab. 1999. PMID: 10599703 Review. No abstract available.

6

Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.

Kurland ES, Cosman F, McMahon DJ, Rosen CJ, Lindsay R, Bilezikian JP. Kurland ES, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 2000 Sep;85(9):3069-76. doi: 10.1210/jcem.85.9.6818. J Clin Endocrinol Metab. 2000. PMID: 10999788 Clinical Trial.

7

Clinical review 123: Anabolic therapy for osteoporosis.

Rosen CJ, Bilezikian JP. Rosen CJ, et al. Among authors: bilezikian jp. J Clin Endocrinol Metab. 2001 Mar;86(3):957-64. doi: 10.1210/jcem.86.3.7366. J Clin Endocrinol Metab. 2001. PMID: 11238469 Review.

8

The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.

Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ; PaTH Study Investigators. Black DM, et al. Among authors: bilezikian jp. N Engl J Med. 2003 Sep 25;349(13):1207-15. doi: 10.1056/NEJMoa031975. Epub 2003 Sep 20. N Engl J Med. 2003. PMID: 14500804 Free article. Clinical Trial.

9

Idiopathic osteoporosis in premenopausal women.

Rubin MR, Schussheim DH, Kulak CA, Kurland ES, Rosen CJ, Bilezikian JP, Shane E. Rubin MR, et al. Among authors: bilezikian jp. Osteoporos Int. 2005 May;16(5):526-33. doi: 10.1007/s00198-004-1716-0. Epub 2004 Aug 5. Osteoporos Int. 2005. PMID: 15300364

10

One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.

Black DM, Bilezikian JP, Ensrud KE, Greenspan SL, Palermo L, Hue T, Lang TF, McGowan JA, Rosen CJ; PaTH Study Investigators. Black DM, et al. Among authors: bilezikian jp. N Engl J Med. 2005 Aug 11;353(6):555-65. doi: 10.1056/NEJMoa050336. N Engl J Med. 2005. PMID: 16093464 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

639 results

Search Page

Filters